This invention relates to a method for assessing risk of prostate cancer. Specifically, it relates to utilizing both Pro108 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In addition, it is directed to a method for assessing risk of ovarian, colon, breast...http://www.google.fr/patents/US7294704?utm_source=gb-gplus-shareBrevet US7294704 - Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
Pro108 antibody compositions and methods of use and use of Pro108 to assess ...
